DENTSPLY SIRONA (NASDAQ:XRAY) PT Raised to $34.00 at Evercore ISI

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) had its price target lifted by equities researchers at Evercore ISI to $34.00 in a report released on Thursday, Stock Target Advisor reports. Evercore ISI’s price target suggests a potential upside of 9.22% from the company’s previous close.

Several other equities analysts have also recently issued reports on the stock. Piper Sandler dropped their price objective on shares of DENTSPLY SIRONA from $38.00 to $29.00 in a research note on Monday, November 14th. Barrington Research dropped their price objective on shares of DENTSPLY SIRONA from $51.00 to $40.00 in a research note on Tuesday. TheStreet cut shares of DENTSPLY SIRONA from a “c” rating to a “d” rating in a research note on Monday, November 14th. William Blair reissued an “underperform” rating on shares of DENTSPLY SIRONA in a research note on Tuesday, November 1st. Finally, Morgan Stanley dropped their price objective on shares of DENTSPLY SIRONA from $42.00 to $39.00 and set an “overweight” rating on the stock in a research note on Tuesday. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $40.70.

DENTSPLY SIRONA Stock Up 1.4 %

XRAY stock opened at $31.13 on Thursday. The company has a fifty day moving average price of $29.91 and a 200 day moving average price of $34.20. DENTSPLY SIRONA has a 12 month low of $26.48 and a 12 month high of $58.70. The company has a market cap of $6.69 billion, a price-to-earnings ratio of 16.56, a price-to-earnings-growth ratio of 3.98 and a beta of 0.95. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.50 and a quick ratio of 1.05.

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) last released its quarterly earnings results on Monday, November 14th. The medical instruments supplier reported $0.41 EPS for the quarter, missing the consensus estimate of $0.59 by ($0.18). DENTSPLY SIRONA had a negative net margin of 20.81% and a positive return on equity of 9.63%. The business had revenue of $947.00 million during the quarter, compared to analysts’ expectations of $1.01 billion. During the same quarter last year, the company earned $0.68 EPS. The firm’s revenue for the quarter was down 8.9% compared to the same quarter last year. Sell-side analysts expect that DENTSPLY SIRONA will post 1.95 earnings per share for the current year.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of large investors have recently added to or reduced their stakes in XRAY. Wipfli Financial Advisors LLC acquired a new stake in DENTSPLY SIRONA in the 3rd quarter valued at about $27,000. Riverview Trust Co grew its stake in DENTSPLY SIRONA by 185.6% in the 3rd quarter. Riverview Trust Co now owns 991 shares of the medical instruments supplier’s stock valued at $28,000 after acquiring an additional 644 shares during the last quarter. SRS Capital Advisors Inc. acquired a new stake in DENTSPLY SIRONA in the 3rd quarter valued at about $28,000. Ellevest Inc. grew its stake in DENTSPLY SIRONA by 281.2% in the 3rd quarter. Ellevest Inc. now owns 1,216 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 897 shares during the last quarter. Finally, SJS Investment Consulting Inc. acquired a new stake in DENTSPLY SIRONA in the 3rd quarter valued at about $35,000. 96.00% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

(Get Rating)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.

Featured Stories

Stock Target Advisor logo

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.